Pharma Pulse: CCT Pledges Net Zero by 2050 and the Role of Financial Discipline in Generic Affordability

In today’s Pharma Pulse, Cold Chain Technologies sets a formal 2050 Net Zero goal to tackle the industry’s Scope 3 emissions, while a new Op/Ed highlights operational discipline as the vital driver for sustaining U.S. generic drug supplies.